(RTTNews) - Hoth Therapeutics, Inc. (HOTH), a clinical-stage biopharmaceutical company, announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2.85 million shares at an offering price of $0.70 per share in a registered direct offeri
1 views
Hoth Therapeutics Unveils $2 Mln Direct Offering Of Shares; Eyes Up To $4.4 Mln With Warrants
(RTTNews) - Hoth Therapeutics, Inc. (HOTH), a clinical-stage biopharmaceutical company, announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2.85 million shares at an…
